- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07442214
View of Cerebral Perfusion in Liver Transplantation (NIRS/Doppler)
Comparison of Carotid Doppler Ultrasonography With Cerebral Oximetry in Assessing Cerebral Perfusion in Liver Transplantation Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Liver transplant surgeries cause intraoperative problems that are difficult to manage from hemodynamic, respiratory, neurological, hematological, and metabolic perspectives due to the nature of liver failure, which affects many organs and systems. Particularly during the anhepatic period, when the healthy graft is integrated into the recipient's vascular system, clamping of the inferior vena cava, one of the two main veins of the hepatic veins, is often required for its connection. This means that a sudden interruption occurs in the blood volume returning to the heart from the lower part of the body, which constitutes half of the total cardiac output.
Cerebral perfusion is also affected during the anhepatic period, and previous studies have observed impaired cerebral perfusion using cerebral oximetry. However, not every clinic has a cerebral oximetry device, and there are factors that limit its use. Some of these factors include high cost, hyperbilirubinemia, variables that disrupt regional blood flow, diabetes, hypertension, and low hemoglobin.
Ultrasound devices are more commonly available in large clinical centers that perform liver transplant surgeries, even for other purposes. It is possible to evaluate the blood flow to the brain using carotid Doppler ultrasonography. The aim of this study is to measure patients' carotid peak systolic and end-diastolic flow and carotid peak systolic flow variability using carotid Doppler ultrasonography and to compare these measurements with cerebral oximetry measurements.
Translated with DeepL.com (free version)
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Battalgazi
-
Malatya, Battalgazi, Turkey (Türkiye), 44280
- Inonu University Turgut Ozal Medical Center.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult patients aged 18-65 years scheduled for elective liver transplantation
- Written informed consent obtained prior to participation
Exclusion Criteria:
- Fulminant hepatic failure
- Hepatic encephalopathy
- Hepatorenal or hepatopulmonary syndrome
- Pre-existing cerebrovascular disease or carotid stenosis
- Severe cardiopulmonary comorbidity
- Refusal to participate
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Adult Patients Undergoing Liver Transplantation
This cohort includes adult patients undergoing elective liver transplantation who were monitored for cerebral perfusion using near-infrared spectroscopy (NIRS) and carotid Doppler ultrasonography.
|
Non-invasive intraoperative monitoring of cerebral perfusion using NIRS and carotid Doppler.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PSv
Time Frame: During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
|
peak systolic velocity (PS) cm/sec)
|
During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
|
|
rSO₂
Time Frame: During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
|
regional cerebral oxygen saturation (%)
|
During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PPV
Time Frame: During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
|
pulse pressure variation (%)
|
During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
|
|
CI
Time Frame: During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
|
cardiac index (L/min/m2)
|
During surgery: T0: Preanhepatic phase T1: Anhepatic phase T2: Neohepatic phase
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Ibarra-Estrada MA, Lopez-Pulgarin JA, Mijangos-Mendez JC, Diaz-Gomez JL, Aguirre-Avalos G. Respiratory variation in carotid peak systolic velocity predicts volume responsiveness in mechanically ventilated patients with septic shock: a prospective cohort study. Crit Ultrasound J. 2015 Dec;7(1):29. doi: 10.1186/s13089-015-0029-1. Epub 2015 Jun 26.
- Rogers CA, Stoica S, Ellis L, Stokes EA, Wordsworth S, Dabner L, Clayton G, Downes R, Nicholson E, Bennett S, Angelini GD, Reeves BC, Murphy GJ. Randomized trial of near-infrared spectroscopy for personalized optimization of cerebral tissue oxygenation during cardiac surgery. Br J Anaesth. 2017 Sep 1;119(3):384-393. doi: 10.1093/bja/aex182.
- Bevan PJ. Should Cerebral Near-infrared Spectroscopy be Standard of Care in Adult Cardiac Surgery? Heart Lung Circ. 2015 Jun;24(6):544-50. doi: 10.1016/j.hlc.2015.01.011. Epub 2015 Feb 7.
- Ohdan H, Mizunuma K, Tashiro H, Tokita D, Hara H, Onoe T, Ishiyama K, Shibata S, Mitsuta H, Ochi M, Nakahara H, Itamoto T, Asahara T. Intraoperative near-infrared spectroscopy for evaluating hepatic venous outflow in living-donor right lobe liver. Transplantation. 2003 Sep 15;76(5):791-7. doi: 10.1097/01.TP.0000074603.36553.BD.
- Holmgaard F, Vedel AG, Lange T, Nilsson JC, Ravn HB. Impact of 2 Distinct Levels of Mean Arterial Pressure on Near-Infrared Spectroscopy During Cardiac Surgery: Secondary Outcome From a Randomized Clinical Trial. Anesth Analg. 2019 Jun;128(6):1081-1088. doi: 10.1213/ANE.0000000000003418.
- Roy A, Pachisia AV, Govil D, Kn J, Patel S, Harne R, Pal D, Reddy DM, Tyagi P, Pattajoshi S. Fluid Responsiveness in Critically Ill Patients Using Carotid Peak Systolic Velocity Variability: A New Frontier. Cureus. 2023 Jul 18;15(7):e42083. doi: 10.7759/cureus.42083. eCollection 2023 Jul.
- Ramsingh D, Staab J, Flynn B. Application of perioperative hemodynamics today and potentials for tomorrow. Best Pract Res Clin Anaesthesiol. 2021 Dec;35(4):551-564. doi: 10.1016/j.bpa.2021.01.005. Epub 2021 Feb 4.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- InonuNIRS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Transplantation
-
Zhi-Jun ZhuNot yet recruitingLiver Transplantation | Auxiliary Liver Transplantation
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationSpain, Australia, France, Germany, Canada, Italy, United Kingdom, Belgium, South Africa, Switzerland, Sweden, United States, Austria, Brazil, Czechia, Denmark, Finland, Hungary, Ireland, Mexico, Netherlands, New Zealand, Poland
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCzechia, France, Italy, Poland, United Kingdom
-
Astellas Pharma Europe Ltd.TerminatedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
Astellas Pharma Europe Ltd.CompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationBelgium, France, Germany, Poland, Spain, United Kingdom
-
The Hospital for Sick ChildrenCompletedLiver Transplantation | Kidney Transplantation | Heart TransplantationCanada
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingLiver Transplantation | Kidney TransplantationFrance
-
Astellas Pharma China, Inc.CompletedLiver Transplantation | Kidney TransplantationChina
-
Astellas Pharma China, Inc.CompletedLiver Transplantation | Kidney TransplantationChina
-
Rennes University HospitalCompletedLiver Transplantation | Kidney TransplantationFrance
Clinical Trials on Carotid Doppler Ultrasonography and Near-Infrared Spectroscopy (NIRS)
-
Ankara UniversityRecruitingPatent Ductus Arteriosus After Premature BirthTurkey
-
Hacettepe UniversityUnknownAnemia of PrematurityTurkey
-
Brigham and Women's HospitalUnknownHypoxia | Infant, Premature, Diseases | Necrotizing EnterocolitisUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSubarachnoid HemorrhageFrance
-
University of AthensTerminatedCOVID-19 Pneumonia | COVID-19 Acute Respiratory Distress SyndromeGreece
-
Centre Hospitalier Universitaire, AmiensCompletedChild | Diagnosis | NIRS | Testicular Torsion | Diagnostic TestFrance
-
University of UtahIntermountain Health Care, Inc.CompletedNecrotizing Enterocolitis | Congenital Heart Disease | Patent Ductus Arteriosus | Infant, PrematureUnited States
-
Nationwide Children's HospitalCompleted
-
Marmara UniversityUnknownNecrotizing EnterocolitisTurkey
-
University Medical Centre LjubljanaSlovenian Research AgencyCompleted